US Stock MarketDetailed Quotes
CNSP CNS Pharmaceuticals
- 0.1325
- -0.0085-6.03%
Close Aug 16 16:00 ET
- 0.1323
- -0.0002-0.15%
Post 19:58 ET
4.26MMarket Cap-1P/E (TTM)
0.1555High0.0955Low5.23MVolume0.1460Open0.1410Pre Close703.73KTurnover21.06%Turnover Ratio0.00P/E (Static)32.15MShares137.500052wk High-0.99P/B3.29MFloat Cap0.095552wk Low--Dividend TTM24.85MShs Float8534.8500Historical High--Div YieldTTM42.55%Amplitude0.0950Historical Low0.1340Avg Price1Lot Size
About CNS Pharmaceuticals Company
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Company Profile
SymbolCNSP
Company NameCNS Pharmaceuticals
Listing DateNov 8, 2019
Issue Price4.00
Founded2017
CEOMr. John M. Climaco
MarketNASDAQ
Employees5
Fiscal Year Ends12-31
Address2100 West Loop South,Suite 900
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77027
Phone1-800-946-9185
Websitehttp://www.cnspharma.com
Company Executives
- Name
- Position
- Salary
- John M. Climaco
- President, Chief Executive Officer and Director
- 624.35K
- Dr. Sandra L. Silberman, PhD
- Chief Medical Officer
- 270.15K
- Dr. Donald H. Picker, PhD
- Chief Science Officer
- --
- Christopher Downs
- Chief Financial Officer and Principal Accounting Officer
- 401.52K
- Faith L. Charles
- Chairman of the Board
- 112.64K
- Jeffry R. Keyes
- Independent Director
- 135.46K
- Carl Evans
- Independent Director
- 114.96K
- Dr. Jerzy Gumulka
- Independent Director
- 115.16K
- Amy Mahery
- Independent Director
- --
- Bettina M. Cockroft
- Independent Director
- 58.31K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg